Immunogenic cell death in cancer and infectious disease

@article{Galluzzi2017ImmunogenicCD,
  title={Immunogenic cell death in cancer and infectious disease},
  author={L. Galluzzi and A. Buqu{\'e} and O. Kepp and L. Zitvogel and G. Kroemer},
  journal={Nature Reviews Immunology},
  year={2017},
  volume={17},
  pages={97-111}
}
Immunogenicity depends on two key factors: antigenicity and adjuvanticity. The presence of exogenous or mutated antigens explains why infected cells and malignant cells can initiate an adaptive immune response provided that the cells also emit adjuvant signals as a consequence of cellular stress and death. Several infectious pathogens have devised strategies to control cell death and limit the emission of danger signals from dying cells, thereby avoiding immune recognition. Similarly, cancer… Expand
Tumor-intrinsic determinants of immunogenic cell death modalities
TLDR
How tumor intrinsic oncogenic factors subvert desirable intratumoral inflammation by suppressing immunogenic cell death is discussed. Expand
Immunogenic Stress and Death of Cancer Cells in Natural and Therapy-Induced Immunosurveillance
TLDR
DAMPs, such as annexin A1, ATP, calreticulin, HMGB1, and type-1 interferons, which are exposed or released from stressed and dying cancer cells in response to ICD inducers and the signal transduction pathways leading to their activation are discussed. Expand
Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy
TLDR
An otherwise poorly understood role for epigenetic drugs as ICD inducers is put forward, and potential therapeutic innovations that aim to induce ICD during epigenetic drug therapy are discussed, generating highly efficacious cancer immunotherapies. Expand
Immunosuppressive cell death in cancer
TLDR
Given that various therapeutic strategies suffer clinical failure or resistance, appropriate animal models or clinical validation are needed to re-examine the immuno logical consequences described above, and there are several lines of evidence that conflict with this Review. Expand
Immunogenic Cell Death Driven by Radiation-Impact on the Tumor Microenvironment.
TLDR
The mechanisms whereby damage-associated molecular patterns emitted by cancer cells undergoing RT-driven ICD alter the functional configuration of the tumor microenvironment are discussed. Expand
Methods to Detect Immunogenic Cell Death In Vivo.
TLDR
Two methods are described that can be harnessed to straightforwardly determine the immunogenicity of mouse cancer cells succumbing to stress in both tumor-naïve and tumor-bearing hosts. Expand
Revisiting immunogenic cell death to improve treatment response in cancer
TLDR
A comprehensive review of ICD-associated mechanisms, and its therapeutic exploitation to provide long-lasting anticancer responses is provided. Expand
Quantification of eIF2alpha phosphorylation during immunogenic cell death.
Immunogenic cell death (ICD) is a particular modality of cell death that can be triggered by selected anticancer chemotherapeutics. Tumor cells undergoing ICD can induce an adaptive anticancer immuneExpand
Immunosurveillance of cancer cell stress
TLDR
How distinct situations of cellular stress influence innate and adaptive immunity and the consequent impact on cancer establishment and progression is explored. Expand
Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses
TLDR
This review exhaustively describes the main molecular, immunological, preclinical, and clinical aspects of immunosuppressive cell death or ICD (with respect to apoptosis, necrosis and necroptosis), and provides an extensive historical background of these fields. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 142 REFERENCES
Immunogenic cell death in cancer therapy.
TLDR
It is postulate that ICD constitutes a prominent pathway for the activation of the immune system against cancer, which in turn determines the long-term success of anticancer therapies and its subversion by pathogens. Expand
Immunogenic cell death and DAMPs in cancer therapy
TLDR
The role of endoplasmic reticulum (ER) stress and reactive oxygen species (ROS) in regulating the immunogenicity of dying cancer cells and the effect of therapy-resistant cancer microevolution on ICD are discussed. Expand
Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity.
TLDR
A genetic model in which direct dimerization of FADD combined with inducible expression of RIPK3 promotes necroptosis is developed, which broadens the current concept of immunogenic cell death and opens doors for the development of new strategies in cancer therapy. Expand
Consensus guidelines for the detection of immunogenic cell death
TLDR
Strategies conceived to detect surrogate markers of ICD in vitro and to screen large chemical libraries for putative I CD inducers are outlined, based on a high-content, high-throughput platform that was recently developed. Expand
Viral subversion of immunogenic cell death
TLDR
It is postulate that obligate intracellular pathogens have developed a variety of strategies to subvert CRT exposure, thereby avoiding immunogenic cell death. Expand
Apoptotic cell clearance: basic biology and therapeutic potential
TLDR
The current understanding of the complex process of apoptotic cell clearance in physiology and pathology is reviewed, and how this knowledge could be harnessed for new therapeutic strategies are discussed. Expand
Inducers of immunogenic cancer cell death.
TLDR
Using inducers of immunogenic cell death (ICD) that can prevent or impede tumour-promoting cytokine signalling is one of the best ways of instigating or restoring efficient anti-tumour immunity. Expand
Calreticulin exposure dictates the immunogenicity of cancer cell death
TLDR
It is shown that anthracyclin-induced CRT translocation induces the rapid, preapoptotic translocation of calreticulin (CRT) to the cell surface and is identified as a key feature determining anticancer immune responses. Expand
Viral Control of Mitochondrial Apoptosis
TLDR
The current knowledge on the viral modulation of mitochondrial apoptosis is summarized, by focusing in particular on the mechanisms by which viral proteins control the host cell death apparatus. Expand
Neoantigens in cancer immunotherapy
TLDR
Observations indicate that neoantigen load may form a biomarker in cancer immunotherapy and provide an incentive for the development of novel therapeutic approaches that selectively enhance T cell reactivity against this class of antigens. Expand
...
1
2
3
4
5
...